Results 1 to 10 of about 804,384 (336)

Targeted radionuclide therapy in combined-modality regimens [PDF]

The Lancet Oncology, 2017
Targeted radionuclide therapy (TRT) is a branch of cancer medicine concerned with the use of radioisotopes, radiolabelled molecules, nanoparticles, or microparticles that either naturally accumulate in or are designed to target tumours. TRT combines the specificity of molecular and sometimes physical targeting with the potent cytotoxicity of ionising ...
Gill, MR, Falzone, N, Du, Y, Vallis, KA
semanticscholar   +8 more sources

Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. [PDF]

Gynecol Oncol, 2019
Objective: To identify the optimal adjuvant treatment regimen for patients with endometrioid and non-endometrioid node-positive endometrial cancer. Methods: We retrospectively identified 249 women with FIGO 2009 stage IIIC endometrial cancer at our ...
Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH.   +11 more
europepmc   +2 more sources

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer. [PDF]

JAMA Oncol, 2018
Importance Combined-modality therapy with chemotherapy and radiation therapy plays a crucial role in the upfront treatment of patients with limited-stage small cell lung cancer (SCLC), but there may be barriers to utilization in the United States ...
Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG.   +9 more
europepmc   +2 more sources

Editorial: Developing combined modality therapy with mitochondria-targeting strategy [PDF]

Frontiers in Oncology, 2023
Yong Teng, Yong Teng
doaj   +2 more sources

Recent advances in combined modality therapy. [PDF]

Oncologist, 2010
Abstract Combined modality therapy emerged from preclinical data showing that carefully chosen drugs could enhance the sensitivity of tumor cells to radiation while having nonoverlapping toxicities. Recent advances in molecular biology involving the identification of cellular receptors, enzymes, and pathways involved in tumor growth and ...
Mierzwa ML, Nyati MK, Morgan MA, Lawrence TS.   +3 more
europepmc   +5 more sources

Case Report: Effective management of residual glioblastoma with combined modality therapy [PDF]

Frontiers in Oncology
Glioblastoma (GBM) is an aggressive primary brain tumor with a poor prognosis, often characterized by rapid progression and resistance to conventional therapies.
Heng-Jui Chang, Chiao-Hsu Ke, Yu-Shan Wang, Yu-Shan Wang, Yu-Cheng Kuo, Yu-Cheng Kuo   +5 more
doaj   +2 more sources

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy

British Journal of Cancer, 2007
There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005).
David Cunningham, Ghaneh P, Cunningham D   +2 more
exaly   +2 more sources

Treatment of Obstructive Sleep Apnea. Prospects for Personalized Combined Modality Therapy. [PDF]

Ann Am Thorac Soc, 2016
Deacon NL, Jen R, Li Y, Malhotra A.
europepmc   +2 more sources

Photodynamic Therapy and Its Role in Combined Modality Anticancer Treatment

Technology in Cancer Research and Treatment, 2015
Chandan Guha, Wolfgang Tome, N Patrik Brodin   +2 more
exaly   +2 more sources

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma

Annals of Oncology, 2013
Bingshu Chen, M K Gospodarowicz, M Crump   +2 more
exaly   +2 more sources